{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:12:44Z","timestamp":1787807564471,"version":"build-2784847793"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"8128","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,8,20]]},"DOI":"10.1038\/s41586-026-10837-5","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:54:24Z","timestamp":1782852864000},"page":"723-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vaccination elicits HIV broadly neutralizing antibodies in primates"],"prefix":"10.1038","volume":"656","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4586-3251","authenticated-orcid":false,"given":"Jon M.","family":"Steichen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4527-5692","authenticated-orcid":false,"given":"Patrick J.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia T.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1272-7712","authenticated-orcid":false,"given":"Swastik","family":"Phulera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monolina","family":"Shil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5273-1951","authenticated-orcid":false,"given":"Oleksandr","family":"Kalyuzhniy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyne","family":"Kifude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh M.","family":"Sewall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-3083","authenticated-orcid":false,"given":"Christopher A.","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal M.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-5160","authenticated-orcid":false,"given":"Sabyasachi","family":"Baboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene K.","family":"Diedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"McKenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1404-4322","authenticated-orcid":false,"given":"Allan C.","family":"deCamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7073-3723","authenticated-orcid":false,"given":"Diane G.","family":"Carnathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7283-4766","authenticated-orcid":false,"given":"Ivy","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-6660","authenticated-orcid":false,"given":"Parham","family":"Ramezani-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1586-404X","authenticated-orcid":false,"given":"Ester","family":"Marina-Z\u00e1rate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Sincomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2874-7010","authenticated-orcid":false,"given":"Ryan","family":"Tingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3848-6280","authenticated-orcid":false,"given":"Nushin","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy S.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyne","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Sovie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L. V.","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Voic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5074-5815","authenticated-orcid":false,"given":"Xiaoya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Pixton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-2454","authenticated-orcid":false,"given":"Mariane B.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Schiffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1130-9463","authenticated-orcid":false,"given":"Facundo D.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6711-9864","authenticated-orcid":false,"given":"Dennis R.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-1405","authenticated-orcid":false,"given":"Darrell J.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4589-5322","authenticated-orcid":false,"given":"James C.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5267-1672","authenticated-orcid":false,"suffix":"III","given":"John R.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-8138","authenticated-orcid":false,"given":"Gabriel","family":"Ozorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-3769","authenticated-orcid":false,"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6602-2470","authenticated-orcid":false,"given":"Guido","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6484-6262","authenticated-orcid":false,"given":"Shane","family":"Crotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-0150","authenticated-orcid":false,"given":"William R.","family":"Schief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"10837_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nri891","volume":"2","author":"DR Burton","year":"2002","unstructured":"Burton, D. R. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2, 706\u2013713 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"10837_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","volume":"31","author":"D Corti","year":"2013","unstructured":"Corti, D. & Lanzavecchia, A. Broadly neutralizing antiviral antibodies. Annu. Rev. Immunol. 31, 705\u2013742 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"10837_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.chom.2019.08.014","volume":"26","author":"A Pegu","year":"2019","unstructured":"Pegu, A. et al. A meta-analysis of passive immunization studies shows that serum-neutralizing antibody titer associates with protection against SHIV challenge. Cell Host Microbe 26, 336\u2013346 (2019).","journal-title":"Cell Host Microbe"},{"key":"10837_CR4","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","volume":"384","author":"L Corey","year":"2021","unstructured":"Corey, L. et al. Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition. N. Engl. J. Med. 384, 1003\u20131014 (2021).","journal-title":"N. Engl. J. Med."},{"key":"10837_CR5","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1038\/s41591-022-01953-6","volume":"28","author":"PB Gilbert","year":"2022","unstructured":"Gilbert, P. B. et al. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition. Nat. Med. 28, 1924\u20131932 (2022).","journal-title":"Nat. Med."},{"key":"10837_CR6","doi-asserted-by":"publisher","unstructured":"Klasse, P. J., Sanders, R. W., Ward, A. B., Wilson, I. A. & Moore, J. P. The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/s41579-025-01206-6 (2025).","DOI":"10.1038\/s41579-025-01206-6"},{"key":"10837_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.bbrc.2009.09.029","volume":"390","author":"X Xiao","year":"2009","unstructured":"Xiao, X. et al. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens. Biochem. Biophys. Res. Commun. 390, 404\u2013409 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10837_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4161\/mabs.2.3.11779","volume":"2","author":"DS Dimitrov","year":"2010","unstructured":"Dimitrov, D. S. Therapeutic antibodies, vaccines and antibodyomes. mAbs 2, 347\u2013356 (2010).","journal-title":"mAbs"},{"key":"10837_CR9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.1234150","volume":"340","author":"J Jardine","year":"2013","unstructured":"Jardine, J. et al. Rational HIV immunogen design to target specific germline B cell receptors. Science 340, 711\u2013716 (2013).","journal-title":"Science"},{"key":"10837_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1084\/jem.20122824","volume":"210","author":"AT McGuire","year":"2013","unstructured":"McGuire, A. T. et al. Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies. J. Exp. Med. 210, 655\u2013663 (2013).","journal-title":"J. Exp. Med."},{"key":"10837_CR11","doi-asserted-by":"publisher","unstructured":"Stamatatos, L. The germline targeting vaccine concept: overview and updates from HIV pre-clinical and clinical trials. Curr. HIV Res. https:\/\/doi.org\/10.2174\/011570162X358302250206074255 (2025).","DOI":"10.2174\/011570162X358302250206074255"},{"key":"10837_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6502","volume":"378","author":"DJ Leggat","year":"2022","unstructured":"Leggat, D. J. et al. Vaccination induces HIV broadly neutralizing antibody precursors in humans. Science 378, eadd6502 (2022).","journal-title":"Science"},{"key":"10837_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf3309","volume":"15","author":"KW Cohen","year":"2023","unstructured":"Cohen, K. W. et al. A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses. Sci. Transl. Med. 15, eadf3309 (2023).","journal-title":"Sci. Transl. Med."},{"key":"10837_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00811-5","volume":"9","author":"AC deCamp","year":"2024","unstructured":"deCamp, A. C. et al. Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming. NPJ Vaccines 9, 58 (2024).","journal-title":"NPJ Vaccines"},{"key":"10837_CR15","doi-asserted-by":"publisher","unstructured":"Willis, J. R. et al. Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans. Science https:\/\/doi.org\/10.1126\/science.adr8382 (2025).","DOI":"10.1126\/science.adr8382"},{"key":"10837_CR16","doi-asserted-by":"publisher","unstructured":"Caniels, T. G. et al. Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science https:\/\/doi.org\/10.1126\/science.adv5572 (2025).","DOI":"10.1126\/science.adv5572"},{"key":"10837_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2510163122","volume":"122","author":"X Lin","year":"2025","unstructured":"Lin, X. et al. Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial. Proc. Natl Acad. Sci. USA 122, e2510163122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10837_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.aac5894","volume":"349","author":"JG Jardine","year":"2015","unstructured":"Jardine, J. G. et al. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science 349, 156\u2013161 (2015).","journal-title":"Science"},{"key":"10837_CR19","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.cell.2015.06.003","volume":"161","author":"P Dosenovic","year":"2015","unstructured":"Dosenovic, P. et al. Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice. Cell 161, 1505\u20131515 (2015).","journal-title":"Cell"},{"key":"10837_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","volume":"45","author":"JM Steichen","year":"2016","unstructured":"Steichen, J. M. et al. HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies. Immunity 45, 483\u2013496 (2016).","journal-title":"Immunity"},{"key":"10837_CR21","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.cell.2016.07.030","volume":"166","author":"A Escolano","year":"2016","unstructured":"Escolano, A. et al. Sequential immunization elicits broadly neutralizing anti-HIV-1 antibodies in Ig knockin mice. Cell 166, 1445\u20131458 (2016).","journal-title":"Cell"},{"key":"10837_CR22","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.cell.2016.08.005","volume":"166","author":"B Briney","year":"2016","unstructured":"Briney, B. et al. Tailored immunogens direct affinity maturation toward HIV neutralizing antibodies. Cell 166, 1459\u20131470 (2016).","journal-title":"Cell"},{"key":"10837_CR23","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.cell.2016.07.029","volume":"166","author":"M Tian","year":"2016","unstructured":"Tian, M. et al. Induction of HIV neutralizing antibody lineages in mice with diverse precursor repertoires. Cell 166, 1471\u20131484 (2016).","journal-title":"Cell"},{"key":"10837_CR24","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1126\/science.aah3945","volume":"353","author":"D Sok","year":"2016","unstructured":"Sok, D. et al. Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice. Science 353, 1557\u20131560 (2016).","journal-title":"Science"},{"key":"10837_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax4380","volume":"366","author":"JM Steichen","year":"2019","unstructured":"Steichen, J. M. et al. A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses. Science 366, eaax4380 (2019).","journal-title":"Science"},{"key":"10837_CR26","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/j.celrep.2019.10.071","volume":"29","author":"KR Parks","year":"2019","unstructured":"Parks, K. R. et al. Overcoming steric restrictions of VRC01 HIV-1 neutralizing antibodies through immunization. Cell Rep. 29, 3060\u20133072 (2019).","journal-title":"Cell Rep."},{"key":"10837_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2020.12.014","volume":"54","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth. Immunity 54, 324\u2013339 (2021).","journal-title":"Immunity"},{"key":"10837_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101003","volume":"4","author":"TG Caniels","year":"2023","unstructured":"Caniels, T. G. et al. Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions. Cell Rep. Med. 4, 101003 (2023).","journal-title":"Cell Rep. Med."},{"key":"10837_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade6364","volume":"8","author":"HB Gristick","year":"2023","unstructured":"Gristick, H. B. et al. CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals. Sci. Immunol. 8, eade6364 (2023).","journal-title":"Sci. Immunol."},{"key":"10837_CR30","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41590-024-01833-w","volume":"25","author":"T Schiffner","year":"2024","unstructured":"Schiffner, T. et al. Vaccination induces broadly neutralizing antibody precursors to HIV gp41. Nat. Immunol. 25, 1073\u20131082 (2024).","journal-title":"Nat. Immunol."},{"key":"10837_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adk9550","volume":"9","author":"TG Caniels","year":"2024","unstructured":"Caniels, T. G. et al. Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site. Sci. Immunol. 9, eadk9550 (2024).","journal-title":"Sci. Immunol."},{"key":"10837_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adt6660","volume":"10","author":"KM Ma","year":"2025","unstructured":"Ma, K. M. et al. HIV broadly neutralizing antibody precursors to the Apex epitope induced in nonhuman primates. Sci. Immunol. 10, eadt6660 (2025).","journal-title":"Sci. Immunol."},{"key":"10837_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adu8878","volume":"10","author":"HJ Sutton","year":"2025","unstructured":"Sutton, H. J. et al. Simultaneous induction of multiple classes of broadly neutralizing antibody precursors by combination germline-targeting immunization in nonhuman primates. Sci. Immunol. 10, eadu8878 (2025).","journal-title":"Sci. Immunol."},{"key":"10837_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adu7961","volume":"10","author":"Z Xie","year":"2025","unstructured":"Xie, Z. et al. Simultaneous priming of HIV broadly neutralizing antibody precursors to multiple epitopes by germline-targeting mRNA-LNP immunogens in mouse models. Sci. Immunol. 10, eadu7961 (2025).","journal-title":"Sci. Immunol."},{"key":"10837_CR35","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","volume":"19","author":"D Sok","year":"2018","unstructured":"Sok, D. & Burton, D. R. Recent progress in broadly neutralizing antibodies to HIV. Nat. Immunol. 19, 1179\u20131188 (2018).","journal-title":"Nat. Immunol."},{"key":"10837_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2016.06.026","volume":"45","author":"D Sok","year":"2016","unstructured":"Sok, D. et al. A prominent site of antibody vulnerability on HIV envelope incorporates a motif associated with CCR5 binding and its camouflaging glycans. Immunity 45, 31\u201345 (2016).","journal-title":"Immunity"},{"key":"10837_CR37","doi-asserted-by":"publisher","unstructured":"Freund, N. T. et al. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aal2144 (2017).","DOI":"10.1126\/scitranslmed.aal2144"},{"key":"10837_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03632-y","volume":"9","author":"CO Barnes","year":"2018","unstructured":"Barnes, C. O. et al. Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope. Nat. Commun. 9, 1251 (2018).","journal-title":"Nat. Commun."},{"key":"10837_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj8321","volume":"384","author":"JM Steichen","year":"2024","unstructured":"Steichen, J. M. et al. Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates. Science 384, eadj8321 (2024).","journal-title":"Science"},{"key":"10837_CR40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.immuni.2025.03.003","volume":"58","author":"PJ Madden","year":"2025","unstructured":"Madden, P. J. et al. Diverse priming outcomes under conditions of very rare precursor B cells. Immunity 58, 997\u20131014 (2025).","journal-title":"Immunity"},{"key":"10837_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-immunol-041015-055531","volume":"35","author":"F Weisel","year":"2017","unstructured":"Weisel, F. & Shlomchik, M. Memory B cells of mice and humans. Annu. Rev. Immunol. 35, 255\u2013284 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"10837_CR42","doi-asserted-by":"publisher","unstructured":"McHeyzer-Williams, L. J., Dufaud, C. & McHeyzer-Williams, M. G. Do memory B cells form secondary germinal centers? Impact of antibody class and quality of memory T-cell help at recall. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a028878 (2018).","DOI":"10.1101\/cshperspect.a028878"},{"key":"10837_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2019.11.032","volume":"180","author":"L Mesin","year":"2020","unstructured":"Mesin, L. et al. Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting. Cell 180, 92\u2013106 (2020).","journal-title":"Cell"},{"key":"10837_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf1152","volume":"6","author":"M Silva","year":"2021","unstructured":"Silva, M. et al. A particulate saponin\/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity. Sci. Immunol. 6, eabf1152 (2021).","journal-title":"Sci. Immunol."},{"key":"10837_CR45","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1128\/JVI.02827-12","volume":"87","author":"S Hoffenberg","year":"2013","unstructured":"Hoffenberg, S. et al. Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes. J. Virol. 87, 5372\u20135383 (2013).","journal-title":"J. Virol."},{"key":"10837_CR46","doi-asserted-by":"publisher","first-page":"e1003618","DOI":"10.1371\/journal.ppat.1003618","volume":"9","author":"RW Sanders","year":"2013","unstructured":"Sanders, R. W. et al. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog. 9, e1003618 (2013).","journal-title":"PLoS Pathog."},{"key":"10837_CR47","doi-asserted-by":"publisher","first-page":"e1011469","DOI":"10.1371\/journal.ppat.1011469","volume":"19","author":"NN Mkhize","year":"2023","unstructured":"Mkhize, N. N. et al. Neutralization profiles of HIV-1 viruses from the VRC01 antibody mediated prevention (AMP) trials. PLoS Pathog. 19, e1011469 (2023).","journal-title":"PLoS Pathog."},{"key":"10837_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ady6831","volume":"17","author":"KR Parks","year":"2025","unstructured":"Parks, K. R. et al. Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial. Sci. Transl. Med. 17, eady6831 (2025).","journal-title":"Sci. Transl. Med."},{"key":"10837_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adw0721","volume":"17","author":"P Ramezani-Rad","year":"2025","unstructured":"Ramezani-Rad, P. et al. Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models. Sci. Transl. Med. 17, eadw0721 (2025).","journal-title":"Sci. Transl. Med."},{"key":"10837_CR50","unstructured":"A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV (ClinicalTrials.gov, 2025); https:\/\/clinicaltrials.gov\/study\/NCT06033209."},{"key":"10837_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2018.11.011","volume":"50","author":"MG Pauthner","year":"2019","unstructured":"Pauthner, M. G. et al. Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum-neutralizing antibody titers. Immunity 50, 241\u2013252 (2019).","journal-title":"Immunity"},{"key":"10837_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1908030","volume":"18","author":"Y Huang","year":"2022","unstructured":"Huang, Y. et al. Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected antibody mediated prevention (AMP) trial participants. Hum. Vaccin. Immunother. 18, 1908030 (2022).","journal-title":"Hum. Vaccin. Immunother."},{"key":"10837_CR53","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.1128\/JVI.00110-09","volume":"83","author":"MD Simek","year":"2009","unstructured":"Simek, M. D. et al. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J. Virol. 83, 7337\u20137348 (2009).","journal-title":"J. Virol."},{"key":"10837_CR54","doi-asserted-by":"publisher","unstructured":"Guenaga, J. et al. Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apex. Nature https:\/\/doi.org\/10.1038\/s41586-026-10429-3 (2026).","DOI":"10.1038\/s41586-026-10429-3"},{"key":"10837_CR55","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.immuni.2026.03.012","volume":"59","author":"N Mishra","year":"2026","unstructured":"Mishra, N. et al. Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques. Immunity 59, 1140\u20131160 (2026).","journal-title":"Immunity"},{"key":"10837_CR56","doi-asserted-by":"publisher","unstructured":"Roark, R. S. et al. Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20250638 (2025).","DOI":"10.1084\/jem.20250638"},{"key":"10837_CR57","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.immuni.2020.08.008","volume":"53","author":"J Finney","year":"2020","unstructured":"Finney, J. & Kelsoe, G. Ideal vaccines: balancing B cell recruitment and differentiation. Immunity 53, 473\u2013475 (2020).","journal-title":"Immunity"},{"key":"10837_CR58","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.immuni.2020.08.001","volume":"53","author":"Y Kato","year":"2020","unstructured":"Kato, Y. et al. Multifaceted effects of antigen valency on B cell response composition and differentiation in vivo. Immunity 53, 548\u2013563 (2020).","journal-title":"Immunity"},{"key":"10837_CR59","unstructured":"Weidner, N. G. et al. Antigen avidity potentiates the durability of the vaccine immune response. Sci. Transl. Med. (in the press)."},{"key":"10837_CR60","unstructured":"Padilla, M. V. et al. Immunization with mosaic nanoparticles reveals that antigen avidity shapes the clonal hierarchy of the B cell response. Sci. Transl. Med. (in the press)."},{"key":"10837_CR61","doi-asserted-by":"publisher","unstructured":"Diazgranados, C. A., Onami, T. & Anklesaria, P. Accelerating Innovation: advancing opportunities in HIV vaccine development. Curr. HIV Res. https:\/\/doi.org\/10.2174\/011570162X364991250710044947 (2025).","DOI":"10.2174\/011570162X364991250710044947"},{"key":"10837_CR62","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41586-022-05216-9","volume":"609","author":"JH Lee","year":"2022","unstructured":"Lee, J. H. et al. Long-primed germinal centres with enduring affinity maturation and clonal migration. Nature 609, 998\u20131004 (2022).","journal-title":"Nature"},{"key":"10837_CR63","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.virol.2008.12.032","volume":"385","author":"SS Kulkarni","year":"2009","unstructured":"Kulkarni, S. S. et al. Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India. Virology 385, 505\u2013520 (2009).","journal-title":"Virology"},{"key":"10837_CR64","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.celrep.2018.03.061","volume":"23","author":"L Rutten","year":"2018","unstructured":"Rutten, L. et al. A universal approach to optimize the folding and stability of prefusion-closed HIV-1 envelope trimers. Cell Rep. 23, 584\u2013595 (2018).","journal-title":"Cell Rep."},{"key":"10837_CR65","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.immuni.2017.04.014","volume":"46","author":"J Guenaga","year":"2017","unstructured":"Guenaga, J. et al. Glycine substitution at helix-to-coil transitions facilitates the structural determination of a stabilized subtype C HIV envelope glycoprotein. Immunity 46, 792\u2013803 (2017).","journal-title":"Immunity"},{"key":"10837_CR66","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1126\/science.aat9120","volume":"363","author":"T Tokatlian","year":"2019","unstructured":"Tokatlian, T. et al. Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers. Science 363, 649\u2013654 (2019).","journal-title":"Science"},{"key":"10837_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-015-0210-4","volume":"12","author":"K Sliepen","year":"2015","unstructured":"Sliepen, K. et al. Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity. Retrovirology 12, 82 (2015).","journal-title":"Retrovirology"},{"key":"10837_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk0582","volume":"384","author":"Z Xie","year":"2024","unstructured":"Xie, Z. et al. mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies. Science 384, eadk0582 (2024).","journal-title":"Science"},{"key":"10837_CR69","doi-asserted-by":"publisher","first-page":"22920","DOI":"10.1073\/pnas.2004489117","volume":"117","author":"D Huang","year":"2020","unstructured":"Huang, D. et al. B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models. Proc. Natl Acad. Sci. USA 117, 22920\u201322931 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10837_CR70","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","volume":"31","author":"NT Gupta","year":"2015","unstructured":"Gupta, N. T. et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356\u20133358 (2015).","journal-title":"Bioinformatics"},{"key":"10837_CR71","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"10837_CR72","doi-asserted-by":"publisher","first-page":"e1009885","DOI":"10.1371\/journal.pcbi.1009885","volume":"18","author":"KB Hoehn","year":"2022","unstructured":"Hoehn, K. B., Pybus, O. G. & Kleinstein, S. H. Phylogenetic analysis of migration, differentiation, and class switching in B cells. PLoS Comput. Biol. 18, e1009885 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"10837_CR73","doi-asserted-by":"publisher","first-page":"22664","DOI":"10.1073\/pnas.1906020116","volume":"116","author":"KB Hoehn","year":"2019","unstructured":"Hoehn, K. B. et al. Repertoire-wide phylogenetic models of B cell molecular evolution reveal evolutionary signatures of aging and vaccination. Proc. Natl Acad. Sci. USA 116, 22664\u201322672 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10837_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn0223","volume":"16","author":"CA Cottrell","year":"2024","unstructured":"Cottrell, C. A. et al. Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice. Sci. Transl. Med. 16, eadn0223 (2024).","journal-title":"Sci. Transl. Med."},{"key":"10837_CR75","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"10837_CR76","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"10837_CR77","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"10837_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","journal-title":"Protein Sci."},{"key":"10837_CR79","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/pro.3791","volume":"29","author":"A Casanal","year":"2020","unstructured":"Casanal, A., Lohkamp, B. & Emsley, P. Current developments in Coot for macromolecular model building of electron cryo-microscopy and crystallographic data. Protein Sci. 29, 1069\u20131078 (2020).","journal-title":"Protein Sci."},{"key":"10837_CR80","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D"},{"key":"10837_CR81","unstructured":"Los Alamos National Laboratory HIV Sequence Database https:\/\/www.hiv.lanl.gov\/content\/immunology (Theor. Biol. Biophys. Group, Los Alamos National Laboratory, 2022)."},{"key":"10837_CR82","doi-asserted-by":"publisher","unstructured":"Baboo, S. et al. DeGlyPHER: an ultrasensitive method for the analysis of viral spike N-glycoforms. Anal. Chem. https:\/\/doi.org\/10.1021\/acs.analchem.1c03059 (2021).","DOI":"10.1021\/acs.analchem.1c03059"},{"key":"10837_CR83","doi-asserted-by":"publisher","first-page":"11361","DOI":"10.1021\/acs.analchem.5b02721","volume":"87","author":"L He","year":"2015","unstructured":"He, L., Diedrich, J., Chu, Y. Y. & Yates, J. R. III Extracting accurate precursor information for tandem mass spectra by RawConverter. Anal. Chem. 87, 11361\u201311367 (2015).","journal-title":"Anal. Chem."},{"key":"10837_CR84","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jprot.2015.07.001","volume":"129","author":"T Xu","year":"2015","unstructured":"Xu, T. et al. ProLuCID: an improved SEQUEST-like algorithm with enhanced sensitivity and specificity. J. Proteomics 129, 16\u201324 (2015).","journal-title":"J. Proteomics"},{"key":"10837_CR85","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1021\/pr015504q","volume":"1","author":"DL Tabb","year":"2002","unstructured":"Tabb, D. L., McDonald, W. H. & Yates, J. R. III DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1, 21\u201326 (2002).","journal-title":"J. Proteome Res."},{"key":"10837_CR86","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/pr025556v","volume":"2","author":"J Peng","year":"2003","unstructured":"Peng, J., Elias, J. E., Thoreen, C. C., Licklider, L. J. & Gygi, S. P. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC\/LC-MS\/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res. 2, 43\u201350 (2003).","journal-title":"J. Proteome Res."},{"key":"10837_CR87","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nmeth.1195","volume":"5","author":"SK Park","year":"2008","unstructured":"Park, S. K., Venable, J. D., Xu, T. & Yates, J. R. III A quantitative analysis software tool for mass spectrometry-based proteomics. Nat. Methods 5, 319\u2013322 (2008).","journal-title":"Nat. Methods"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10837-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T07:02:06Z","timestamp":1787209326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10837-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":87,"journal-issue":{"issue":"8128","published-print":{"date-parts":[[2026,8,20]]}},"alternative-id":["10837"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10837-5","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.M.S., C.A.C., T. Schiffner and W.R.S. are listed as inventors on patent applications related to immunogens in this Article filed by Scripps and IAVI. S.C. and D.J.I. are listed as inventors on patent applications related to SMNP. W.R.S. is an employee and shareholder of Moderna. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}